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Female	 genital	 tuberculosis	 (FGTB)	 classically	 presents	
with	infertility,	pelvic	pain,	or	menstrual	irregularities,	with	
or	without	other	systemic	symptoms	of	tuberculosis.[1]	Such	
symptoms	 and	 resulting	 debilitation	 as	well	 as	 economic	
costs	can	have	serious	detrimental	effects	on	women’s	quality	





is due to the challenges of limited health‑care utilization 




inflammatory	 disease	 (PID)	 and/or	 infertility,	 published	
data from high tuberculosis burden settings indicate a high 
prevalence	of	FGTB.[5]
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EPTB	are	higher	among	females	as	compared	to	males,[6] as 
has	also	been	observed	in	studies	from	South	Asia.[7]	However,	
tuberculosis control program data are not disaggregated by the 
site	of	EPTB	and	sex‑disaggregated	data	on	incidence	cannot	
be	used	to	estimate	FGTB	burden.
In	an	effort	 to	better	define	 the	FGTB	epidemiology	 in	 the	
high‑burden	country	of	Pakistan,	we	examined	data	from	a	
referral	 laboratory	 to	 report	 culture‑confirmed	FGTB	 rates	
among	 females	 evaluated	 for	 tuberculosis.	These	 data	 are	
important to inform the need for guideline development, 
facilitated referral for improved health‑care delivery and 




We	 report	 on	 data	 from	Pakistan,	 a	 high‑burden	 country	
with	 an	 incidence	 of	 tuberculosis	 of	 263	 per	 100,000	
population,[8]	 41%	of	 total	 cases	occurring	 in	women.	This	






















culture	 results	was	 retrieved	 from	2007	 to	2016,	 and	other	
variables in the database included sex, age, specimen type, 
cultured	isolate	identification	(Mycobacterium tuberculosis or 





We	used	the	ISPOR[9]	and	STROBE[10] checklists to evaluate 
the	 standard	 of	 reporting	 for	 this	 descriptive	 analysis.	An	






Extrapulmonary specimens (except cerebrospinal fluid) 
were	decontaminated	and	liquid	cultures	were	continuously	
monitored	for	evidence	of	growth	for	6	weeks.	The	laboratory	
subscribed	 to	 proficiency	 testing	 program	by	CAP	during	
the	 study	 period	 and	 obtained	 satisfactory	 results.	Culture	
contamination rates during the 10‑year study period remained 
within	the	recommended	benchmark	of	5%–8%.[11]
Data abstraction and analysis
Data	 downloaded	 from	 laboratory	 servers	were	 extracted	






entries	 for	 specimen	 type	and	patient	 identification	numbers	
were	removed	in	batches.	Data	quality	checks	and	verification	
were	performed	by	comparison	to	source	data.	Any	conflicts	
were	 resolved	by	 consultation	with	 the	 author	 group.	Data	
were	 refined	by	 type	of	FGTB	 specimen	 source,	 including	
endometrial tissue, endometrial curettage sample, tubo‑ovarian 











The	 study	was	 reviewed	 and	 exempted	 from	 individual	
informed	consent	 by	 the	Ethical	Review	Committee	of	 the	
Aga	Khan	University,	Pakistan.
results
Study population and laboratory utilization
From	 2007	 to	 2016,	 the	 study	 laboratory	 received	
410,748	 specimens	 for	mycobacterial	 culture.	The	male:	





Culture positivity and extrapulmonary tuberculosis rates 
among females
Among	a	total	of	177,463	cultures	from	females,	11,544	(6.5%)	
were	 positive	 for	M. tuberculosis complex (MTB), and 
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1889	 (16.4%)	 of	 these	 positive	 cultures	 were	 from	
extrapulmonary	specimen	sources.	Rifampin	resistance	(RR)	
was	 observed	 more	 frequently	 in	 PTB	 in	 females	 at	
47.5%	 (n	 =	 4583),	while	 it	 remained	 low	 in	EPTB	 cases	
in	 females	 at	 15.8%	 (n	 =	 298)	 (P	 <	 0.0001;	Chi‑square).	
FGTB	was	responsible	for	1.8%	of	all	culture‑positive	EPTB	
specimens	 in	 females.	 Figure	 1	 shows	 cultures	 received,	
positivity	rates,	and	RR	among	PTB	and	EPTB	in	females	of	
all	age	groups.
Culture‑confirmed female genital tuberculosis




tubo‑ovarian	 and	one	 endometrial	 specimens	were	 received	
from	one	patient),	31	were	females	15–49	years,	with	a	median	
age	of	26.5	(32–25)	years.	Clinical	indications,	age,	and	linked	
specimen positivity details are presented in Table	1.
Among	 culture‑confirmed	FGTB,	 infertility	was	 the	most	






granulomatous	 inflammation	with	epithelioid	 cells	 and	giant	
cells	with	or	without	 caseous	necrosis.	RR	was	observed	 in	
3	patients	in	endometrial	specimens.	Of	the	two	RR	patients,	







however,	 is	 not	 indicative	 of	 the	 incidence	 or	 prevalence	
of	FGTB.	Data	 from	evaluation	 cohorts	 among	women	of	
reproductive	 age	with	 infertility	 and	PID	 in	Pakistan	 have	
reported	higher	rates	of	FGTB	(3%–3.5%).[12,13]	Furthermore,	
when	 performed	 in	 subsets	 of	women	with	 infertility	 or	
associated symptoms, the yield of laparoscopic diagnosis 
is	 44%,	 and	 of	mycobacterial	 culture	 and/or	 nucleic	 acid,	
detection	by	polymerase	chain	reaction‑based	tests	is	10%,[14] 




or	 histopathological	 examination	 of	 endometrial	 tissue.[15] 





The	 low	 proportion	 of	 culture‑confirmed	 tuberculosis	
observed in our data, despite the expected high prevalence 
of	 FGTB,	 may	 be	 a	 function	 of	 any	 of	 the	 following	
factors:	 paucibacillary	 nature	 and	 low	 culture	 yield	 of	
genital specimens (endometrium), lack of availability or 
reduced	 utilization	 of	molecular	methods	with	 presumed	
higher sensitivity,[14]	use	of	private	laboratory	services	with	
data that are not captured by national programs or in this 
study,	 or	 lack	 of	 access	 to	 health‑care	 services	 required	
for	 the	 appropriate	 diagnosis	 and	management	 of	 FGTB.	
Each of these factors likely contributes to the traditional 
understanding	of	FGTB	as	a	“rare”	form	of	tuberculosis	in	
women	even	 in	high‑burden	 settings.	A	 recent	 evaluation	
of	EPTB	in	Pakistan	for	the	year	2016	in	public	health‑care	
facilities notifying tuberculosis to national authorities, 
however,	reveals	that	data	are	either	not	segregated	by	source	
or the proportion of genitourinary specimens submitted 















Development	 of	 new	 and	 improved	 diagnostic	 tools	 and	
Figure 1: Culture‑confirmed tuberculosis among females in Pakistan 
based on data from a large laboratory network 2007–2016. Figures 
in the table represent total numbers of culture‑positive specimens. 
MTB: Mycobacterium tuberculosis complex, RR: Rifampin‑resistant 
tuberculosis, PTB: Pulmonary tuberculosis, EPTB: Extrapulmonary 
tuberculosis, FGTB: Female genital tuberculosis
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their	application	to	diagnosis	of	FGTB	should	be	advocated	
to	 improve	 case	 detection	 and	 confidence	 in	 diagnosis.[17] 
Implementation	of	these	diagnostic	modalities	would	require	




to evaluate appropriate and innovative methods for specimen 
collection	and	integrated	diagnosis.
HIV	status	of	women	was	not	known	and	linked	laboratory	
and	 hospital	 databases	 for	 the	 32	women	with	 FGTB	did	
not reveal if any of them had been evaluated for diabetes or 
prediabetes.	Some	limitations	of	this	study	which	stem	from	
the	 study	 design	 are	 important	 to	 note.	The	 retrospective	
nature	of	the	study	did	not	allow	us	to	address	the	proportion	
of	FGTB	among	all	women	of	reproductive	age	group	who	
were	 evaluated	 for	 gynecological	 complaints.	 Specimen	
source‑wise	negative	cultures	could	not	be	extracted	from	the	
laboratory’s	electronic	database.	We	were	also	unable	to	access	
an independent database of histopathological examinations 
to evaluate the culture‑negative proportion of granulomatous 
endometritis	and	salpingitis.	Limitations	of	this	study	noted	
above highlight the need for program linkages and electronic 
databases.
Improved	 surveillance	 for	 FGTB	 paired	with	 uptake	 of	
complementary	and	enhanced	diagnostic	methods	in	women	
is	 needed	 in	 Pakistan.	Neither	Xpert	 nor	 histopathology	
services	 are	widely	 available	 to	 allow	 improved	 diagnosis	
which	 highlights	 the	 need	 for	 facilitated	 referral.	The	 low	
positivity	rates	of	culture	in	FGTB	should	lead	to	advocacy	
for research into and implementation of improved diagnostic 
methods	and	strategies.
Table 1: Demographics, clinical indications, and microbiological and histopathological details of 32 women with 
culture‑confirmed female genital tuberculosis diagnosed at a countrywide laboratory network, 2007‑2016
Clinical indication Age Source City Year Microbiological Histopathological
Smear Culture Rifampin
Infertility 23 E Karachi 2008 ‑ MTB S Chronic	granulomatous	inflammation
23 E Karachi 2009 ‑ MTB S Chronic	granulomatous	inflammation
25 E Karachi 2009 ‑ MTB S Chronic	granulomatous	inflammation
25 E Peshawar 2010 ‑ MTB R Benign late secretory endometrium
30 E Karachi 2010 ‑ MTB S Chronic	granulomatous	inflammation
27 E Karachi 2012 ‑ MTB S NA
28 E Karachi 2013 ‑ MTB S Normal endometrial tissue
34 E Karachi 2007 ‑ MTB S Normal endometrial tissue
27 E Karachi 2009 ‑ MTB S Chronic	granulomatous	inflammation	and	necrosis
26 E Karachi 2010 ‑ MTB S Normal endometrial tissue
41 E Karachi 2010 ‑ MTB S Benign endometrial epithelium
26 E Karachi 2011 ‑ MTB S Chronic	granulomatous	inflammation
30 E Karachi 2014 ‑ MTB S Chronic	granulomatous	inflammation	and	necrosis
35 E Karachi 2014 ‑ MTB S Chronic	granulomatous	inflammation	and	necrosis
31 TO Karachi 2007 ‑ MTB S Chronic	granulomatous	inflammation
25 TO Quetta 2016 ‑ MTB S Chronic	granulomatous	inflammation	and	necrosis
Menstrual	irregularities/
amenorrhea
26 E Karachi 2007 ‑ MTB S Benign endometrial epithelium
22 PA Karachi 2009 ‑ MTB S Chronic	granulomatous	inflammation
Postcoital	bleeding 34 C Karachi 2008 ‑ MTB S Cervical	polyp,	chronic	nonspecific	inflammation
Abdominal	pain 30 E Karachi 2015 ‑ MTB S Chronic	granulomatous	inflammation
30 TO Karachi 2010 ‑ MTB S Chronic	granulomatous	inflammation
17 TO Karachi 2014 ‑ MTB S Chronic	granulomatous	inflammation
52 E Mianwali 2015 ‑ MTB S Chronic	granulomatous	inflammation
Ectopic pregnancy 25 TO	+	E Karachi 2009 ‑ MTB S Endometrium:	Chronic	granulomatous	inflammation
Unknown 32 E Karachi 2009 + MTB R NA
15 E Karachi 2011 ‑ MTB S Chronic	granulomatous	inflammation
24 E Karachi 2011 ‑ MTB S NA
25 E Karachi 2011 ‑ MTB S Chronic	granulomatous	inflammation	with	necrosis
26 E Karachi 2013 ‑ MTB S NA
35 E Karachi 2010 ‑ MTB R Abnormal	secretory	endometrium	with	glandular	
and	stromal	breakdown
26 E Karachi 2014 ‑ MTB S Chronic	granulomatous	inflammation
45 E Abbottabad 2012 ‑ MTB S Chronic	granulomatous	inflammation
E:	Endometrium,	TO:	Tubo‑ovarian,	C:	Cervical,	PA:	Pelvic	adhesions,	MTB:	Mycobacterium tuberculosis	complex,	NA:	Not	available,	R:	Resistant,	
S:	Susceptible
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